Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:450-458
Published online before print December 26, 2006, doi: 10.1161/CIRCULATIONAHA.106.637793
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: January 30, 2007, Volume 115, Number 4
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/4/450    most recent
CIRCULATIONAHA.106.637793v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sarwar, N.
Right arrow Articles by Gudnason, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarwar, N.
Right arrow Articles by Gudnason, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2007;115:450-458.)
© 2007 American Heart Association, Inc.


Epidemiology

Triglycerides and the Risk of Coronary Heart Disease

10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies

Nadeem Sarwar, MPhil; John Danesh, DPhil; Gudny Eiriksdottir, MSc; Gunnar Sigurdsson, PhD; Nick Wareham, PhD; Sheila Bingham, PhD; S. Matthijs Boekholdt, PhD; Kay-Tee Khaw, MBBChir; Vilmundur Gudnason, PhD

From the Department of Public Health and Primary Care, University of Cambridge (N.S., J.D., K.-T.K.), MRC Epidemiology Unit (N.W.), MRC Dunn Nutrition Unit, and MRC Centre for Nutrition and Cancer Prevention and Survival (S.B.), Cambridge, England; Icelandic Heart Association, Kopavogur, Iceland (G.E., G.S., V.G.); and Academic Medical Center, Amsterdam, the Netherlands (S.M.B.).

Correspondence to Professor John Danesh, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort’s Causeway, Cambridge, CB1 8RN, UK. E-mail john.danesh{at}phpc.cam.ac.uk

Received May 2, 2006; revision received September 13, 2006; accepted September 29, 2006.

Background— Many epidemiological studies have reported on associations between serum triglyceride concentrations and the risk of coronary heart disease, but this association has not been reliably quantified. In the present study, we report 2 separate nested case-control comparisons in 2 different prospective, population-based cohorts, plus an updated meta-analysis of 27 additional prospective studies in general Western populations.

Methods and Results— Measurements were made in a total of 3582 incident cases of fatal and nonfatal coronary heart disease and 6175 controls selected from among the 44 237 men and women screened in the Reykjavik and the European Prospective Investigation of Cancer (EPIC)-Norfolk studies. Repeat measurements were obtained an average of 4 years apart in 1933 participants in the EPIC-Norfolk Study and an average of 12 years apart in 379 participants in the Reykjavik study. The long-term stability of log-triglyceride values (within-person correlation coefficients of 0.64 [95% CI, 0.60 to 0.68] over 4 years and 0.63 [95% CI, 0.57 to 0.70] over 12 years) was similar to those of blood pressure and total serum cholesterol. After adjustment for baseline values of several established risk factors, the strength of the association was substantially attenuated, and the adjusted odds ratio for coronary heart disease was 1.76 (95% CI, 1.39 to 2.21) in the Reykjavik study and 1.57 (95% CI, 1.10 to 2.24) in the EPIC-Norfolk study in a comparison of individuals in the top third with those in the bottom third of usual log-triglyceride values. Similar overall findings (adjusted odds ratio, 1.72; 95% CI, 1.56 to 1.90) were observed in an updated meta-analysis involving a total of 10 158 incident coronary heart disease cases from 262 525 participants in 29 studies.

Conclusions— Available prospective studies in Western populations consistently indicate moderate and highly significant associations between triglyceride values and coronary heart disease risk. Because these associations depend considerably on levels of established risk factors, however, further studies are needed to help assess the nature of any independent associations.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2007 115: 427. [Full Text]



This article has been cited by other articles:


Home page
Int J EpidemiolHome page
S. Bingham, R. Luben, A. Welch, Y. L. Low, K. T. Khaw, N. Wareham, and N. Day
Associations between dietary methods and biomarkers, and between fruits and vegetables and risk of ischaemic heart disease, in the EPIC Norfolk Cohort Study
Int. J. Epidemiol., June 25, 2008; (2008) dyn111v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. D Furtado, H. Campos, L. J Appel, E. R Miller, N. Laranjo, V. J Carey, and F. M Sacks
Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1623 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. A. Frempong, M. Ricks, S. Sen, and A. E. Sumner
Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2097 - 2103.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Svensson, E. B. Schmidt, K. A. Jorgensen, and J. H. Christensen
The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study
Nephrol. Dial. Transplant., April 24, 2008; (2008) gfn180v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation
J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1512 - 1524.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Diabetes Care, April 1, 2008; 31(4): 811 - 822.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. O. Lowe, J. Danesh, and V. Gudnason
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data
Arch Intern Med, March 24, 2008; 168(6): 598 - 608.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. M. Broadbent, J. F. Peden, S. Lorkowski, A. Goel, H. Ongen, F. Green, R. Clarke, R. Collins, M. G. Franzosi, G. Tognoni, et al.
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
Hum. Mol. Genet., March 15, 2008; 17(6): 806 - 814.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Miller, C. P. Cannon, S. A. Murphy, J. Qin, K. K. Ray, E. Braunwald, and for the PROVE IT-TIMI 22 Investigators
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 724 - 730.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Zhang, R. Qi, X. Xian, F. Yang, M. Blackstein, X. Deng, J. Fan, C. Ross, J. Karasinska, M. R. Hayden, et al.
Spontaneous Atherosclerosis in Aged Lipoprotein Lipase-Deficient Mice With Severe Hypertriglyceridemia on a Normal Chow Diet
Circ. Res., February 1, 2008; 102(2): 250 - 256.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. M Ridker
Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Clin. Chem., January 1, 2008; 54(1): 11 - 13.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Wang, H. Cao, M. R. Ban, B. A. Kennedy, S. Zhu, S. Anand, S. Yusuf, R. L. Pollex, and R. A. Hegele
Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650)
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2450 - 2455.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Tirosh, A. Rudich, T. Shochat, D. Tekes-Manova, E. Israeli, Y. Henkin, I. Kochba, and I. Shai
Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men
Ann Intern Med, September 18, 2007; 147(6): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. H. Criqui
Triglycerides and Coronary Heart Disease Revisited (Again)
Ann Intern Med, September 18, 2007; 147(6): 425 - 427.
[Full Text] [PDF]


Home page
JAMAHome page
B. G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
JAMA, July 18, 2007; 298(3): 299 - 308.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Bansal, J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M Ridker
Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
JAMA, July 18, 2007; 298(3): 309 - 316.
[Abstract] [Full Text] [PDF]